Majority of Pediatric Antidepressant Industry Trials Considered Low Quality
Meta-analyses including studies that detail these trials could be presenting misleading information.
Two Thirds of Patients See Physicians Who Receive Payments From Pharma
Study finds more patients are visiting physicians who have ties to industry than previously thought.
‘Do Antidepressants Work?’ is the Wrong Question
“This research points to the inadequacy of asking the simple question: ‘Do antidepressants work?’ Instead, the value or otherwise of antidepressants needs to be understood in the context of the diversity of experience and the particular meaning they hold in people’s lives.”
New Data Show Lack of Efficacy for Antidepressants
An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.
College Course Offered on Calling out Scientific Crap
From STAT: Two professors at the University of Washington will be offering a new course, "Calling Bullshit In the Age of Big Data." The class...
Neuroscience-based Treatment Program Proposed for Adolescent Depression
A study published in Frontiers in Human Neuroscience proposes a new model for the treatment of adolescents diagnosed with major depressive disorder (MDD).
Treating Metabolic Conditions May Resolve Some Depressive Symptoms
New research suggests that treatable metabolic abnormalities underlie some treatment-resistant cases of depression—and treating the metabolic condition has the possibility of dramatically reducing depressive symptoms
Industry Funded Trials Favor Drugs Over Psychotherapy
The researchers conclude that industry funding appears to bias studies towards pharmacotherapy over psychotherapy for the treatment of depression.
“For One Condition, the Drugs Came Before the Disorder”
An investigative report in the Milwaukee-Wisconsin Journal Sentinel explores the pharmaceutical industries involvement in the creation of the ‘mental illness’ known as Premenstrual Dysphoric Disorder...
How ‘Premenstrual Dysphoric Disorder’ was Created by Pharma
For MinnPost, Susan Perry discusses that the pharmaceutical industry played in the creation of the ‘mental disorder’ known as premenstrual dysphoric disorder or PMDD....
Review Questions Long Term Use of Antipsychotics
Patients who recover from a single episode of psychosis are often prescribed antipsychotics long-term, despite a lack of evidence for this practice
“A Frenzy Of Lobbying On 21st Century Cures”
Kaiser Health News and NPR report on the immense lobbying effort aimed at passing the "21st Century Cures" Act which would fast-track FDA approval...
Safety Analysis Weighs Harms and Benefits of Antipsychotic Drugs
The researchers find that the drug effects for reducing psychosis are small and that treatment failure and severe side effects are common.
Study Finds No Benefit for Testosterone Treatments
Researchers find no benefits for testosterone as a treatment for improving mood, psychological well-being, and cognitive function.
Pharma Data Sharing Efforts Off to a Slow Start
Researchers discuss the preliminary results of clinical trial data sharing efforts by pharmaceutical companies and other groups.
“How the FDA Manipulates the Media”
The Scientific American reports that the FDA offered scoops to major media organizations but, in exchange, the news agencies had to agree only to...
German Psychologists Declare “the Drugs Don’t Work”
Jürgen Margraf and Silvia Schneider, both well-known psychologists at the University of Bochum in Germany, claim that psychotropic drugs are no solution to mental...
Ghostwriting has a New Name but Same Problems
A new paper, published in the British Medical Journal, explains how the pharmaceutical industry has publicly denounced ghostwriting while still finding ways to engage...
Psychiatric Drug Ads Lead to More Prescriptions and Worse Treatment
A new analysis published in the The Journal of Clinical Psychiatry investigates the public health effects of direct-to-consumer advertisements for psychiatric drugs. The researchers...
“The Drug Docs”
In part six of a seven-part “Drugging Our Kids” series by The Mercury News, Karen de Sa and Tracy Seipel unveil California’s top foster...
Researchers Pressure Psychiatric Journal to Retract Misleading Celexa Study
In 2004, the American Psychiatric Association published a paper supporting the use of the antidepressant citalopram (Celexa) in children and teens. After reanalyzing the...
“Health News Review and What’s Wrong (and Right) With the Media”
HealthNewsReview.org founder Gary Schwitzer talks to New York Magazine on the media coverage of medical research. “We in journalism have to look in the mirror...
“Selling Side Effects: Big Pharma’s Marketing Machine?”
Drug Watch releases an in-depth investigation into the marketing practices of pharmaceutical companies in the United States. “Companies spend billions advertising to doctors to...
Despite Official Recommendations, Depression Screening in Children is Not Supported by Research
Earlier this year, the US Preventative Services Task Force (USPSTF) came out with the controversial recommendation that all adolescent and adult patients undergo depression...
How Does the News Cover Mental Health Issues?
The news media frequently write stories that connect mental health issues with violence, according to a new study published this month in Health Affairs....
